-
[Illinois] ECE 416: Biosensors
07 Feb 2013 | | Contributor(s):: Brian Cunningham
Learn the underlying engineering principles used to detect small molecules, DNA, proteins, and cells in the context of applications in diagnostic testing, pharmaceutical research, and environmental monitoring. Biosensor approaches including electrochemistry, fluorescence,...
-
[Illinois] Gold Nanostars as Tiny Hitchhikers for Cancer Therapeutics
01 Aug 2014 | | Contributor(s):: Teri Odom
-
[Illinois] How to Break the "Fundamental" Limits of Nanobiosensing
07 Apr 2014 | | Contributor(s):: Muhammad A. Alam
As the future of Moore’s law of transistor scaling appears uncertain, electronics is being reinvented by broadening the focus to other areas including macroelectronics (electronics of large, possibly flexible and transparent displays), bioelectronics (e.g., nanobio sensors for genomics,...
-
[Illinois] Nanotechnology meets Biology in the Cancer Cell: Applications in Medicine, Drug Delivery, and Determining Drug Efficacy
04 Feb 2016 | | Contributor(s):: Mostafa El-Sayed
-
[Illinois] Plasmonic Engineering in Nanomedicine
28 Apr 2014 | | Contributor(s):: Srikanth Singamaneni
Plasmonics involves the control of light at the nanoscale using surface plasmons. One particular area where plasmonics is expected to make an enoromous impact is the field of life sciences, with applications in bioimaging, biosensing, and targted and externally-triggered therapy. In the first...
-
[Illinois] Translational Nanomedicine from Drug Discovery to Preclinical Studies
10 Nov 2015 | | Contributor(s):: Dipanjan Pan
-
[Illinois] Translational Nanomedicine in the Interface of Chemistry, Biology, and Engineering
26 Aug 2014 | | Contributor(s):: Dipanjan Pan
-
[Illinois] Translational Nanomedicines Using Biomedical Nanomaterials
02 Aug 2014 | | Contributor(s):: Sei Kwang Hahn
Nano-medicine is the term for the use of advanced bio- and nano-technologies for the development of medicines. In this seminar, smart translational nanomedicines using biomedical nanomaterials will be presented for drug delivery and tissue engineering applications. The first part will cover...
-
"Who Owns Truth?" - Biomedical Research in a Health Policy Context
30 Mar 2009 | | Contributor(s):: Samuel A. Richmond
This presentation examines a claim made by PhRMA on behalf of pharmaceutical manufacturing companies of America, and the response of the International Committee of Medical Journal Editors (ICMJE) questioning drug company publication policies and practices. Also considered are changes in law...